Replies to post #113457 on Biotech Values

[ghmm]

I think Actelion has also been looking at compounds in this area. I don't know how successful they have been or where they are at. The link below says they are in Phase 2 in MS with results expected this year but I am not sure how up-to-date the page is.

http://www1.actelion.com/en/scientists/development-pipeline/phase-2/s1p1-agonist.page